[Comparison of the effectiveness and toxicity of parenteral and oral vepesid in the treatment of disseminated breast cancer].
Voznyĭ
E K
EK
Buianov
S S
SS
Biakhov
M Iu
MIu
Dobrovol'skaia
N Iu
NIu
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage* / Q000633:toxicity*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013997:Time Factors
D015251:Epirubicin; D005047:Etoposide; D003520:Cyclophosphamide
Sravnenie éffektivnosti i toksichnosti parenteral'noĭ i peroral'noĭ form vepezida pri lechenii rasprostranennogo raka molochnoĭ zhelezy.